Recent Quotes (30 days)

You have no recent quotes
chg | %

Angiotech Pharmaceuticals, Inc

Find more results for Barr Pharmaceuticals, Inc.�

Officers and directors

John Barr
Chief Executive Officer
Victor Diaz
Omar Vaishnavi


355 Burrard St Suite 1100
Vancouver, BC
+1-604-221-7676 (Phone)
604-221-2330 (Fax)

Website links

Angiotech Pharmaceuticals wants doctors to get the most out of single-use medical devices. The company's Medical Device Technologies segment makes the Quill wound closure system and other single-use medical products and device components for interventional radiology (cancer treatment), ophthalmology (optical care), wound care, and other surgical procedures. Through its Licensed Technologies segment, the company has also developed medical products that combine devices with drugs to make them more effective, such as the TAXUS drug-eluting stent, which Boston Scientific markets (paying Angiotech royalties on TAXUS sales). Angiotech restructured and emerged from Canadian bankruptcy protection during 2011.

Related companies